asthma%20(pediatric)
ASTHMA (PEDIATRIC)

Asthma is a chronic inflammatory disease of the airways in the lungs of children and adults.
The patient usually complains of shortness of breath, chest tightness and coughing with wheezing.

A diagnosis of asthma in young children is more likely if they have symptom patterns, presence of risk factors for development of asthma and therapeutic response to controller treatment.
Goals of treatment are effective symptom control with minimal or no exacerbations, minimal or no nocturnal and daytime symptoms, no limitations on activities, minimal or no need for reliever treatment, and minimal adverse effects of medication.

Asthma (Pediatric) Drug Information

Drug Information

Indication: Bronchial asthma.

Indication: Reduction of sputum viscosity.

Indication: Symptomatic treatment of seasonal or perennial rhinitis in adults & childn ≥3 yr & acute rhinosinus...

Indication: Rheumatic fever, RA, allergic diseases, nephritic syndrome, bronchial asthma & other corticosteroid-indica...

Indication: Relief of bronchospasm in asthma, chronic bronchitis, other conditions involving airways obstruction.

Indication: Resp disorders associated w/ viscid mucus.

Indication: Prophylaxis & treatment of perennial & seasonal allergic rhinitis & vasomotor rhinitis.

Indication: Prevention & treatment of seasonal & perennial allergic rhinitis & vasomotor rhinitis.

Indication: Relief & prevention of asthma & COPD symptoms. Relieve attacks of acute breathlessness due to reversib...

Indication: Controller/preventer therapy in mild, moderate or severe asthma. Asthma management requiring corticosteroid tr...

3  /  18
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 21 Nov 2020
Antiviral treatment with tenofovir alafenamide fumarate (TAF) during pregnancy in highly viraemic mothers effectively prevents mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with no safety concerns, according to two studies presented during the AASLD 2020 Liver Meeting.